Squamous Cell Carcinoma of Esophagus Not Yet Recruiting Phase 2 Trials for Camrelizumab (DB14776)

Also known as: ESOPHAGEAL SQUAMOUS CELL CARCINOMA / Oesophageal squamous cell carcinoma / Esophageal Squamous Cell Carcinomas / Esophageal squamous cell carcinoma stage unspecified / Oesophageal epidermoid carcinoma NOS / Esophageal epidermoid carcinoma NOS / Squamous cell carcinoma of oesophagus / Squamous cell carcinoma of esophagus NOS / Oesophageal squamous cell carcinoma NOS / Oesophageal squamous cell carcinoma stage unspecified

IndicationStatusPhase
DBCOND0031573 (Squamous Cell Carcinoma of Esophagus)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03985046Camrelizumab vs Placebo as Maintenance Therapy After dCRT in Locally Advanced ESCCTreatment
NCT03817658A Phase II Study of SHR-1210 vs Placebo as Consolidation Chemotherapy After Radical Concurrent Chemoradiotherapy in Locally Advanced ESCCTreatment